Rigenerand is an Italy-based biomedical company that provides cell-based biotechnology solutions such as 3-D cell cultures and cancer gene therapies for the biotech industry.
Business Model:
Revenue: $2.1M
Employees: 11-50
Rigenerand was acquired by
Evotec.
The acquisition happend on 2022-05-30.
Details of the transaction were not public
Address: Via Maestri del Lavoro, 4
City: Medolla
State: emilia-romagna
Zip: 41036
Country: IT
Rigenerand is an Italy-based biomedical company that provides cell-based biotechnology solutions such as 3-D cell cultures and cancer gene therapies for the biotech industry.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2016 | Venture Round | 1 | $9.9M |
Principia SGR Principia SGR |
5/2016 | Venture Round | 1 | $9.9M |
Principia SGR Principia SGR |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|